Quick Answer
ENDONOVO THERAPEUTICS, INC. reported Operating Income of -$3.26 million for fiscal year 2022.
ENDONOVO THERAPEUTICS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2022 | -$3.26M | -46.6% |
| 2021 | -$2.23M | +23.5% |
| 2020 | -$2.91M | +23.5% |
| 2019 | -$3.81M | +8.4% |
| 2018 | -$4.16M | +9.7% |
| 2017 | -$4.60M | +14.9% |
| 2016 | -$5.41M | -111.0% |
| 2015 | -$2.56M | -17.0% |
| 2014 | -$2.19M | -2193.9% |
| 2011 | -$95.5K | -22.5% |
| 2010 | -$78.0K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | -$472.8K | +4.8% | +58.2% |
| June 30, 2023 | -$1.13M | +37.1% | -113.7% |
| March 31, 2023 | -$529.3K | -9.0% | -6.5% |
| September 30, 2022 | -$496.8K | +28.2% | +72.4% |
| June 30, 2022 | -$1.80M | -215.5% | -270.3% |
| March 31, 2022 | -$485.8K | +17.7% | +29.8% |
| September 30, 2021 | -$692.3K | +26.9% | -21.4% |
| June 30, 2021 | -$570.1K | +5.3% | +3.5% |
- ENDONOVO THERAPEUTICS, INC. showed a decrease of -46.6% in Operating Income compared to the prior fiscal year.
- Over the 2010–2022 period, ENDONOVO THERAPEUTICS, INC.’s operating income has declined by 4085.8% (from -$78.0 thousand to -$3.26 million).
- The most recent figure is from ENDONOVO THERAPEUTICS, INC.’s fiscal year 2022 report (Form 10-K), filed with the SEC on April 17, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: